Global Microarray Patch Transdermal Drug Delivery Systems Market Research Report 2023

Report ID: 1738652 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Microarray Patch Transdermal Drug Delivery Systems Market Overview
    1.1 Product Overview and Scope of Microarray Patch Transdermal Drug Delivery Systems
    1.2 Microarray Patch Transdermal Drug Delivery Systems Segment by Type
        1.2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Solid Microneedles
        1.2.3 Hollow Microneedles
        1.2.4 Dissolving Microneedles
    1.3 Microarray Patch Transdermal Drug Delivery Systems Segment by Application
        1.3.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Specialty Clinics
        1.3.5 Others
    1.4 Global Microarray Patch Transdermal Drug Delivery Systems Market Size Estimates and Forecasts
        1.4.1 Global Microarray Patch Transdermal Drug Delivery Systems Revenue 2017-2028
        1.4.2 Global Microarray Patch Transdermal Drug Delivery Systems Sales 2017-2028
        1.4.3 Microarray Patch Transdermal Drug Delivery Systems Market Size by Region: 2017 Versus 2021 Versus 2028
2 Microarray Patch Transdermal Drug Delivery Systems Market Competition by Manufacturers
    2.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Microarray Patch Transdermal Drug Delivery Systems Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Microarray Patch Transdermal Drug Delivery Systems Manufacturing Sites, Area Served, Product Type
    2.5 Microarray Patch Transdermal Drug Delivery Systems Market Competitive Situation and Trends
        2.5.1 Microarray Patch Transdermal Drug Delivery Systems Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Microarray Patch Transdermal Drug Delivery Systems Players Market Share by Revenue
        2.5.3 Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario by Region
    3.1 Global Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Microarray Patch Transdermal Drug Delivery Systems Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
        3.3.1 North America Microarray Patch Transdermal Drug Delivery Systems Sales by Country
        3.3.2 North America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
        3.4.1 Europe Microarray Patch Transdermal Drug Delivery Systems Sales by Country
        3.4.2 Europe Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Region
        3.5.1 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales by Region
        3.5.2 Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
        3.6.1 Latin America Microarray Patch Transdermal Drug Delivery Systems Sales by Country
        3.6.2 Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Market Facts & Figures by Country
        3.7.1 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales by Country
        3.7.2 Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Microarray Patch Transdermal Drug Delivery Systems Historic Market Analysis by Type
    4.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Type (2017-2022)
    4.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Type (2017-2022)
    4.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Type (2017-2022)
5 Global Microarray Patch Transdermal Drug Delivery Systems Historic Market Analysis by Application
    5.1 Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Application (2017-2022)
    5.2 Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Application (2017-2022)
    5.3 Global Microarray Patch Transdermal Drug Delivery Systems Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 3M
        6.1.1 3M Corporation Information
        6.1.2 3M Description and Business Overview
        6.1.3 3M Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 3M Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.1.5 3M Recent Developments/Updates
    6.2 Becton
        6.2.1 Becton Corporation Information
        6.2.2 Becton Description and Business Overview
        6.2.3 Becton Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Becton Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.2.5 Becton Recent Developments/Updates
    6.3 Endoderma
        6.3.1 Endoderma Corporation Information
        6.3.2 Endoderma Description and Business Overview
        6.3.3 Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Endoderma Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.3.5 Endoderma Recent Developments/Updates
    6.4 BD
        6.4.1 BD Corporation Information
        6.4.2 BD Description and Business Overview
        6.4.3 BD Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 BD Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.4.5 BD Recent Developments/Updates
    6.5 Zosano Pharma
        6.5.1 Zosano Pharma Corporation Information
        6.5.2 Zosano Pharma Description and Business Overview
        6.5.3 Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.5.5 Zosano Pharma Recent Developments/Updates
    6.6 Raphas
        6.6.1 Raphas Corporation Information
        6.6.2 Raphas Description and Business Overview
        6.6.3 Raphas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 Raphas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.6.5 Raphas Recent Developments/Updates
    6.7 Nanopass Tech
        6.6.1 Nanopass Tech Corporation Information
        6.6.2 Nanopass Tech Description and Business Overview
        6.6.3 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.7.5 Nanopass Tech Recent Developments/Updates
    6.8 Corium International
        6.8.1 Corium International Corporation Information
        6.8.2 Corium International Description and Business Overview
        6.8.3 Corium International Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Corium International Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.8.5 Corium International Recent Developments/Updates
    6.9 Valeritas
        6.9.1 Valeritas Corporation Information
        6.9.2 Valeritas Description and Business Overview
        6.9.3 Valeritas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Valeritas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.9.5 Valeritas Recent Developments/Updates
    6.10 Nitto Denko
        6.10.1 Nitto Denko Corporation Information
        6.10.2 Nitto Denko Description and Business Overview
        6.10.3 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.10.5 Nitto Denko Recent Developments/Updates
    6.11 Microdermics
        6.11.1 Microdermics Corporation Information
        6.11.2 Microdermics Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.11.3 Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Microdermics Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.11.5 Microdermics Recent Developments/Updates
    6.12 TheraJect
        6.12.1 TheraJect Corporation Information
        6.12.2 TheraJect Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.12.3 TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 TheraJect Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.12.5 TheraJect Recent Developments/Updates
    6.13 Vaxxas
        6.13.1 Vaxxas Corporation Information
        6.13.2 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.13.3 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.13.5 Vaxxas Recent Developments/Updates
    6.14 KINDEVA
        6.14.1 KINDEVA Corporation Information
        6.14.2 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.14.3 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.14.5 KINDEVA Recent Developments/Updates
    6.15 QuadMedicine
        6.15.1 QuadMedicine Corporation Information
        6.15.2 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.15.3 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.15.5 QuadMedicine Recent Developments/Updates
    6.16 SNvia
        6.16.1 SNvia Corporation Information
        6.16.2 SNvia Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.16.3 SNvia Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 SNvia Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.16.5 SNvia Recent Developments/Updates
    6.17 Small Lab
        6.17.1 Small Lab Corporation Information
        6.17.2 Small Lab Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.17.3 Small Lab Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.17.4 Small Lab Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.17.5 Small Lab Recent Developments/Updates
    6.18 Lohmann Therapie-Systeme
        6.18.1 Lohmann Therapie-Systeme Corporation Information
        6.18.2 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.18.3 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.18.4 Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.18.5 Lohmann Therapie-Systeme Recent Developments/Updates
    6.19 AdminMed Nano BioSciences
        6.19.1 AdminMed Nano BioSciences Corporation Information
        6.19.2 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Description and Business Overview
        6.19.3 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales, Revenue and Gross Margin (2017-2022)
        6.19.4 AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product Portfolio
        6.19.5 AdminMed Nano BioSciences Recent Developments/Updates
7 Microarray Patch Transdermal Drug Delivery Systems Manufacturing Cost Analysis
    7.1 Microarray Patch Transdermal Drug Delivery Systems Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Microarray Patch Transdermal Drug Delivery Systems
    7.4 Microarray Patch Transdermal Drug Delivery Systems Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Microarray Patch Transdermal Drug Delivery Systems Distributors List
    8.3 Microarray Patch Transdermal Drug Delivery Systems Customers
9 Microarray Patch Transdermal Drug Delivery Systems Market Dynamics
    9.1 Microarray Patch Transdermal Drug Delivery Systems Industry Trends
    9.2 Microarray Patch Transdermal Drug Delivery Systems Market Drivers
    9.3 Microarray Patch Transdermal Drug Delivery Systems Market Challenges
    9.4 Microarray Patch Transdermal Drug Delivery Systems Market Restraints
10 Global Market Forecast
    10.1 Microarray Patch Transdermal Drug Delivery Systems Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Microarray Patch Transdermal Drug Delivery Systems by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Microarray Patch Transdermal Drug Delivery Systems by Type (2023-2028)
    10.2 Microarray Patch Transdermal Drug Delivery Systems Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Microarray Patch Transdermal Drug Delivery Systems by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Microarray Patch Transdermal Drug Delivery Systems by Application (2023-2028)
    10.3 Microarray Patch Transdermal Drug Delivery Systems Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Microarray Patch Transdermal Drug Delivery Systems by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Microarray Patch Transdermal Drug Delivery Systems by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Microarray Patch Transdermal Drug Delivery Systems Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Microarray Patch Transdermal Drug Delivery Systems Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Microarray Patch Transdermal Drug Delivery Systems Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Microarray Patch Transdermal Drug Delivery Systems Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Microarray Patch Transdermal Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Microarray Patch Transdermal Drug Delivery Systems Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Microarray Patch Transdermal Drug Delivery Systems Manufacturing Sites and Area Served
    Table 11. Manufacturers Microarray Patch Transdermal Drug Delivery Systems Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Microarray Patch Transdermal Drug Delivery Systems by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microarray Patch Transdermal Drug Delivery Systems as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Microarray Patch Transdermal Drug Delivery Systems Sales by Region (2017-2022) & (K Units)
    Table 16. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Region (2017-2022)
    Table 17. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Region (2017-2022)
    Table 19. North America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
    Table 20. North America Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
    Table 21. North America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
    Table 23. Europe Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
    Table 25. Europe Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
    Table 33. Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Country (2017-2022)
    Table 39. Global Microarray Patch Transdermal Drug Delivery Systems Sales by Type (2017-2022) & (K Units)
    Table 40. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Type (2017-2022)
    Table 41. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Type (2017-2022)
    Table 43. Global Microarray Patch Transdermal Drug Delivery Systems Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Microarray Patch Transdermal Drug Delivery Systems Sales (K Units) by Application (2017-2022)
    Table 45. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Application (2017-2022)
    Table 46. Global Microarray Patch Transdermal Drug Delivery Systems Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Application (2017-2022)
    Table 48. Global Microarray Patch Transdermal Drug Delivery Systems Price by Application (2017-2022) & (US$/Unit)
    Table 49. 3M Corporation Information
    Table 50. 3M Description and Business Overview
    Table 51. 3M Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. 3M Microarray Patch Transdermal Drug Delivery Systems Product
    Table 53. 3M Recent Developments/Updates
    Table 54. Becton Corporation Information
    Table 55. Becton Description and Business Overview
    Table 56. Becton Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Becton Microarray Patch Transdermal Drug Delivery Systems Product
    Table 58. Becton Recent Developments/Updates
    Table 59. Endoderma Corporation Information
    Table 60. Endoderma Description and Business Overview
    Table 61. Endoderma Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Endoderma Microarray Patch Transdermal Drug Delivery Systems Product
    Table 63. Endoderma Recent Developments/Updates
    Table 64. BD Corporation Information
    Table 65. BD Description and Business Overview
    Table 66. BD Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. BD Microarray Patch Transdermal Drug Delivery Systems Product
    Table 68. BD Recent Developments/Updates
    Table 69. Zosano Pharma Corporation Information
    Table 70. Zosano Pharma Description and Business Overview
    Table 71. Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Zosano Pharma Microarray Patch Transdermal Drug Delivery Systems Product
    Table 73. Zosano Pharma Recent Developments/Updates
    Table 74. Raphas Corporation Information
    Table 75. Raphas Description and Business Overview
    Table 76. Raphas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. Raphas Microarray Patch Transdermal Drug Delivery Systems Product
    Table 78. Raphas Recent Developments/Updates
    Table 79. Nanopass Tech Corporation Information
    Table 80. Nanopass Tech Description and Business Overview
    Table 81. Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Nanopass Tech Microarray Patch Transdermal Drug Delivery Systems Product
    Table 83. Nanopass Tech Recent Developments/Updates
    Table 84. Corium International Corporation Information
    Table 85. Corium International Description and Business Overview
    Table 86. Corium International Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Corium International Microarray Patch Transdermal Drug Delivery Systems Product
    Table 88. Corium International Recent Developments/Updates
    Table 89. Valeritas Corporation Information
    Table 90. Valeritas Description and Business Overview
    Table 91. Valeritas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Valeritas Microarray Patch Transdermal Drug Delivery Systems Product
    Table 93. Valeritas Recent Developments/Updates
    Table 94. Nitto Denko Corporation Information
    Table 95. Nitto Denko Description and Business Overview
    Table 96. Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Nitto Denko Microarray Patch Transdermal Drug Delivery Systems Product
    Table 98. Nitto Denko Recent Developments/Updates
    Table 99. Microdermics Corporation Information
    Table 100. Microdermics Description and Business Overview
    Table 101. Microdermics Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Microdermics Microarray Patch Transdermal Drug Delivery Systems Product
    Table 103. Microdermics Recent Developments/Updates
    Table 104. TheraJect Corporation Information
    Table 105. TheraJect Description and Business Overview
    Table 106. TheraJect Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. TheraJect Microarray Patch Transdermal Drug Delivery Systems Product
    Table 108. TheraJect Recent Developments/Updates
    Table 109. Vaxxas Corporation Information
    Table 110. Vaxxas Description and Business Overview
    Table 111. Vaxxas Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Vaxxas Microarray Patch Transdermal Drug Delivery Systems Product
    Table 113. Vaxxas Recent Developments/Updates
    Table 114. KINDEVA Corporation Information
    Table 115. KINDEVA Description and Business Overview
    Table 116. KINDEVA Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. KINDEVA Microarray Patch Transdermal Drug Delivery Systems Product
    Table 118. KINDEVA Recent Developments/Updates
    Table 119. QuadMedicine Corporation Information
    Table 120. QuadMedicine Description and Business Overview
    Table 121. QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. QuadMedicine Microarray Patch Transdermal Drug Delivery Systems Product
    Table 123. QuadMedicine Recent Developments/Updates
    Table 124. SNvia Corporation Information
    Table 125. SNvia Description and Business Overview
    Table 126. SNvia Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. SNvia Microarray Patch Transdermal Drug Delivery Systems Product
    Table 128. SNvia Recent Developments/Updates
    Table 129. Small Lab Corporation Information
    Table 130. Small Lab Description and Business Overview
    Table 131. Small Lab Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 132. Small Lab Microarray Patch Transdermal Drug Delivery Systems Product
    Table 133. Small Lab Recent Developments/Updates
    Table 134. Lohmann Therapie-Systeme Corporation Information
    Table 135. Lohmann Therapie-Systeme Description and Business Overview
    Table 136. Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 137. Lohmann Therapie-Systeme Microarray Patch Transdermal Drug Delivery Systems Product
    Table 138. Lohmann Therapie-Systeme Recent Developments/Updates
    Table 139. AdminMed Nano BioSciences Corporation Information
    Table 140. AdminMed Nano BioSciences Description and Business Overview
    Table 141. AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 142. AdminMed Nano BioSciences Microarray Patch Transdermal Drug Delivery Systems Product
    Table 143. AdminMed Nano BioSciences Recent Developments/Updates
    Table 144. Production Base and Market Concentration Rate of Raw Material
    Table 145. Key Suppliers of Raw Materials
    Table 146. Microarray Patch Transdermal Drug Delivery Systems Distributors List
    Table 147. Microarray Patch Transdermal Drug Delivery Systems Customers List
    Table 148. Microarray Patch Transdermal Drug Delivery Systems Market Trends
    Table 149. Microarray Patch Transdermal Drug Delivery Systems Market Drivers
    Table 150. Microarray Patch Transdermal Drug Delivery Systems Market Challenges
    Table 151. Microarray Patch Transdermal Drug Delivery Systems Market Restraints
    Table 152. Global Microarray Patch Transdermal Drug Delivery Systems Sales Forecast by Type (2023-2028) & (K Units)
    Table 153. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share Forecast by Type (2023-2028)
    Table 154. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 155. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share Forecast by Type (2023-2028)
    Table 156. Global Microarray Patch Transdermal Drug Delivery Systems Sales Forecast by Application (2023-2028) & (K Units)
    Table 157. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share Forecast by Application (2023-2028)
    Table 158. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 159. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share Forecast by Application (2023-2028)
    Table 160. Global Microarray Patch Transdermal Drug Delivery Systems Sales Forecast by Region (2023-2028) & (K Units)
    Table 161. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share Forecast by Region (2023-2028)
    Table 162. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 163. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share Forecast by Region (2023-2028)
    Table 164. Research Programs/Design for This Report
    Table 165. Key Data Information from Secondary Sources
    Table 166. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Microarray Patch Transdermal Drug Delivery Systems
    Figure 2. Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Type in 2021 & 2028
    Figure 3. Solid Microneedles Product Picture
    Figure 4. Hollow Microneedles Product Picture
    Figure 5. Dissolving Microneedles Product Picture
    Figure 6. Global Microarray Patch Transdermal Drug Delivery Systems Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Ambulatory Surgical Centers
    Figure 9. Specialty Clinics
    Figure 10. Others
    Figure 11. Global Microarray Patch Transdermal Drug Delivery Systems Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Microarray Patch Transdermal Drug Delivery Systems Market Size (2017-2028) & (US$ Million)
    Figure 13. Global Microarray Patch Transdermal Drug Delivery Systems Sales (2017-2028) & (K Units)
    Figure 14. Microarray Patch Transdermal Drug Delivery Systems Sales Share by Manufacturers in 2021
    Figure 15. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Share by Manufacturers in 2021
    Figure 16. The Global 5 and 10 Largest Microarray Patch Transdermal Drug Delivery Systems Players: Market Share by Revenue in 2021
    Figure 17. Microarray Patch Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Region (2017-2022)
    Figure 19. Global Microarray Patch Transdermal Drug Delivery Systems Sales Market Share by Region in 2021
    Figure 20. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Region (2017-2022)
    Figure 21. Global Microarray Patch Transdermal Drug Delivery Systems Revenue Market Share by Region in 2021
    Figure 22. United States Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Canada Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Germany Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. France Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. U.K. Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Italy Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Russia Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. China Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Japan Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. South Korea Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. India Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Australia Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. China Taiwan Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Indonesia Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Thailand Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Malaysia Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Mexico Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Brazil Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Argentina Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Colombia Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Microarray Patch Transdermal Drug Delivery Systems Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Microarray Patch Transdermal Drug Delivery Systems by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Microarray Patch Transdermal Drug Delivery Systems
    Figure 47. Manufacturing Process Analysis of Microarray Patch Transdermal Drug Delivery Systems
    Figure 48. Microarray Patch Transdermal Drug Delivery Systems Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
3M
Becton
Endoderma
BD
Zosano Pharma
Raphas
Nanopass Tech
Corium International
Valeritas
Nitto Denko
Microdermics
TheraJect
Vaxxas
KINDEVA
QuadMedicine
SNvia
Small Lab
Lohmann Therapie-Systeme
AdminMed Nano BioSciences
Frequently Asked Questions
Microarray Patch Transdermal Drug Delivery Systems report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Microarray Patch Transdermal Drug Delivery Systems report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Microarray Patch Transdermal Drug Delivery Systems report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

OBD II Scanners

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More